Department of Clinical Biochemistry, Hammurabi College of Medicine, University of Babylon, Hilla, 51001, Iraq.
International Journal of Science and Research Archive, 2025, 14(01), 967-972
Article DOI: 10.30574/ijsra.2025.14.1.0134
Received on 05 December 2024; revised on 16 January 2025; accepted on 19 January 2025
Background: The coronavirus disease 2019 (COVID‐19) has rapidly developed into a pandemic. Increased levels of ferritin due to cytokine storm and secondary hemophagocytic lymphohistiocytosis were found in severe COVID‐19 patients. Therefore, the aim of this study was to evaluate the role of ferritin level as indicator for positive chest CT. scan.
Patients and methods: 185 Patients involved through February to June. In this study, the blood sample was collected in patients suffering from fever, sore throat with or without dry cough. Then S.ferritin was estimated and after that we did chest-scan.
Result: 164 patients were positive findings for chest- Cscan finding at the level from 10-410 ng/ml of ferritin.
Conclusion: Serum ferritin is a valuable marker that can aid in triaging and determining the need for CT chest imaging in suspected COVID-19 cases. However, its use should be integrated with a broader clinical assessment to ensure appropriate and effective management
Serum ferritin; CT chest indication; COVID-19; ICU and cytokine storm
Preview Article PDF
Safa Amer Ali, Asmaa Hamza Radeef and Ahmed Faisal Obed. Serum ferritin as a guide for CT chest indication in patients suspected to COVID-19. International Journal of Science and Research Archive, 2025, 14(01), 967-972. Article DOI: https://doi.org/10.30574/ijsra.2025.14.1.0134.
Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0